These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Best Practices in Utilization of 2D-NMR Spectral Data as the Input for Chemometric Analysis in Biopharmaceutical Applications. Brinson RG; Arbogast LW; Marino JP; Delaglio F J Chem Inf Model; 2020 Apr; 60(4):2339-2355. PubMed ID: 32249579 [TBL] [Abstract][Full Text] [Related]
3. Chemometric Outlier Classification of 2D-NMR Spectra to Enable Higher Order Structure Characterization of Protein Therapeutics. Sheen DA; Shen VK; Brinson RG; Arbogast LW; Marino JP; Delaglio F Chemometr Intell Lab Syst; 2020; 199():. PubMed ID: 34135539 [TBL] [Abstract][Full Text] [Related]
4. Principal component analysis for automated classification of 2D spectra and interferograms of protein therapeutics: influence of noise, reconstruction details, and data preparation. Brinson RG; Elliott KW; Arbogast LW; Sheen DA; Giddens JP; Marino JP; Delaglio F J Biomol NMR; 2020 Nov; 74(10-11):643-656. PubMed ID: 32700053 [TBL] [Abstract][Full Text] [Related]
5. Application of NMR and Chemometric Analyses to Better Understand the Quality Attributes in pH and Thermally Degraded Monoclonal Antibodies. Beaumont VA; Liu L; Shi H; Rouse JC; Kim HY Pharm Res; 2023 Oct; 40(10):2457-2467. PubMed ID: 37798537 [TBL] [Abstract][Full Text] [Related]
6. Correlated analytical and functional evaluation of higher order structure perturbations from oxidation of NISTmAb. Solomon TL; Delaglio F; Giddens JP; Marino JP; Yu YB; Taraban MB; Brinson RG MAbs; 2023; 15(1):2160227. PubMed ID: 36683157 [TBL] [Abstract][Full Text] [Related]
11. A Comparison Between Emerging and Current Biophysical Methods for the Assessment of Higher-Order Structure of Biopharmaceuticals. Wen J; Batabyal D; Knutson N; Lord H; Wikström M J Pharm Sci; 2020 Jan; 109(1):247-253. PubMed ID: 31669605 [TBL] [Abstract][Full Text] [Related]
12. NMR spectroscopy as a characterization tool enabling biologics formulation development. Ma J; Pathirana C; Liu DQ; Miller SA J Pharm Biomed Anal; 2023 Jan; 223():115110. PubMed ID: 36308923 [TBL] [Abstract][Full Text] [Related]
13. Comprehensive characterization of higher order structure changes in methionine oxidized monoclonal antibodies via NMR chemometric analysis and biophysical approaches. Li M; Beaumont VA; Akbar S; Duncan H; Creasy A; Wang W; Sackett K; Marzilli L; Rouse JC; Kim HY MAbs; 2024; 16(1):2292688. PubMed ID: 38117548 [TBL] [Abstract][Full Text] [Related]
18. Utility of High Resolution NMR Methods to Probe the Impact of Chemical Modifications on Higher Order Structure of Monoclonal Antibodies in Relation to Antigen Binding. Majumder S; Saati A; Philip S; Liu LL; Stephens E; Rouse JC; Alphonse Ignatius A Pharm Res; 2019 Jul; 36(9):130. PubMed ID: 31264003 [TBL] [Abstract][Full Text] [Related]
19. Use of the 2D Hwang TL; Batabyal D; Knutson N; Wikström M Molecules; 2021 May; 26(9):. PubMed ID: 34063095 [TBL] [Abstract][Full Text] [Related]
20. NIST Interlaboratory Study on Glycosylation Analysis of Monoclonal Antibodies: Comparison of Results from Diverse Analytical Methods. De Leoz MLA; Duewer DL; Fung A; Liu L; Yau HK; Potter O; Staples GO; Furuki K; Frenkel R; Hu Y; Sosic Z; Zhang P; Altmann F; Grunwald-Grube C; Shao C; Zaia J; Evers W; Pengelley S; Suckau D; Wiechmann A; Resemann A; Jabs W; Beck A; Froehlich JW; Huang C; Li Y; Liu Y; Sun S; Wang Y; Seo Y; An HJ; Reichardt NC; Ruiz JE; Archer-Hartmann S; Azadi P; Bell L; Lakos Z; An Y; Cipollo JF; Pucic-Bakovic M; Štambuk J; Lauc G; Li X; Wang PG; Bock A; Hennig R; Rapp E; Creskey M; Cyr TD; Nakano M; Sugiyama T; Leung PA; Link-Lenczowski P; Jaworek J; Yang S; Zhang H; Kelly T; Klapoetke S; Cao R; Kim JY; Lee HK; Lee JY; Yoo JS; Kim SR; Suh SK; de Haan N; Falck D; Lageveen-Kammeijer GSM; Wuhrer M; Emery RJ; Kozak RP; Liew LP; Royle L; Urbanowicz PA; Packer NH; Song X; Everest-Dass A; Lattová E; Cajic S; Alagesan K; Kolarich D; Kasali T; Lindo V; Chen Y; Goswami K; Gau B; Amunugama R; Jones R; Stroop CJM; Kato K; Yagi H; Kondo S; Yuen CT; Harazono A; Shi X; Magnelli PE; Kasper BT; Mahal L; Harvey DJ; O'Flaherty R; Rudd PM; Saldova R; Hecht ES; Muddiman DC; Kang J; Bhoskar P; Menard D; Saati A; Merle C; Mast S; Tep S; Truong J; Nishikaze T; Sekiya S; Shafer A; Funaoka S; Toyoda M; de Vreugd P; Caron C; Pradhan P; Tan NC; Mechref Y; Patil S; Rohrer JS; Chakrabarti R; Dadke D; Lahori M; Zou C; Cairo C; Reiz B; Whittal RM; Lebrilla CB; Wu L; Guttman A; Szigeti M; Kremkow BG; Lee KH; Sihlbom C; Adamczyk B; Jin C; Karlsson NG; Örnros J; Larson G; Nilsson J; Meyer B; Wiegandt A; Komatsu E; Perreault H; Bodnar ED; Said N; Francois YN; Leize-Wagner E; Maier S; Zeck A; Heck AJR; Yang Y; Haselberg R; Yu YQ; Alley W; Leone JW; Yuan H; Stein SE Mol Cell Proteomics; 2020 Jan; 19(1):11-30. PubMed ID: 31591262 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]